Northeast Pharmaceutical Group Co., Ltd. (SHE:000597)
China · Delayed Price · Currency is CNY 5.32
-0.11 (-2.03%)
Apr 9, 2026, 2:40 PM CST
SHE:000597 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Net Income | 217.83 | 409.85 | 358.46 | 350.25 | 99.03 |
Depreciation & Amortization | 542.08 | 565.18 | 574.81 | 561.11 | 550.91 |
Other Amortization | 7.77 | 7.74 | 0.27 | 0.36 | 2.29 |
Loss (Gain) From Sale of Assets | -0.26 | -6.19 | -0.17 | -419.3 | -3.29 |
Asset Writedown & Restructuring Costs | 169.76 | 17.83 | 3.9 | 7.97 | 28.96 |
Loss (Gain) From Sale of Investments | -7.81 | -5.16 | -8.61 | - | -54.32 |
Provision & Write-off of Bad Debts | - | -5.45 | -5.62 | 21.92 | 13.14 |
Other Operating Activities | 96.93 | 219.65 | 329.64 | 273.03 | 224.56 |
Change in Accounts Receivable | 101.58 | -82.53 | 149.06 | 115.04 | -268.93 |
Change in Inventory | 99.69 | 57.14 | -150.94 | -5.64 | 8.27 |
Change in Accounts Payable | -112.79 | -528.69 | -747.71 | 151.82 | 160.33 |
Change in Other Net Operating Assets | -0.12 | 22.18 | 102.54 | 59.37 | -1.19 |
Operating Cash Flow | 1,106 | 758.76 | 586.75 | 1,109 | 746.51 |
Operating Cash Flow Growth | 45.81% | 29.32% | -47.07% | 48.50% | 30.75% |
Capital Expenditures | -97.78 | -159.43 | -235.43 | -244.13 | -119.81 |
Sale of Property, Plant & Equipment | 5.56 | 2.7 | 7.47 | 2.67 | 3.83 |
Cash Acquisitions | - | -127.24 | - | -14.89 | - |
Divestitures | - | - | - | - | -0 |
Investment in Securities | 2.86 | - | - | - | 15.9 |
Investing Cash Flow | -89.37 | -283.97 | -227.96 | -256.34 | -100.07 |
Short-Term Debt Issued | - | 6,112 | 5,985 | - | - |
Long-Term Debt Issued | 2,848 | 1,772 | 2,760 | 3,051 | 3,877 |
Total Debt Issued | 2,848 | 7,884 | 8,745 | 3,051 | 3,877 |
Short-Term Debt Repaid | - | -6,843 | -4,167 | - | - |
Long-Term Debt Repaid | -2,334 | -2,470 | -2,857 | -3,382 | -4,092 |
Total Debt Repaid | -2,334 | -9,313 | -7,024 | -3,382 | -4,092 |
Net Debt Issued (Repaid) | 513.8 | -1,429 | 1,721 | -331.23 | -215.4 |
Issuance of Common Stock | - | - | - | 234.78 | - |
Repurchase of Common Stock | - | - | -14.22 | - | -7.36 |
Common Dividends Paid | -196.9 | -206.14 | -219.78 | -109.46 | -165.52 |
Other Financing Activities | -555.85 | 481.62 | -1,106 | 146.92 | 255.88 |
Financing Cash Flow | -238.95 | -1,153 | 381.1 | -58.99 | -132.39 |
Foreign Exchange Rate Adjustments | -23.81 | 9.68 | 6.29 | 6.91 | -1.68 |
Net Cash Flow | 754.26 | -668.96 | 746.18 | 800.16 | 512.36 |
Free Cash Flow | 1,009 | 599.34 | 351.32 | 864.44 | 626.7 |
Free Cash Flow Growth | 68.29% | 70.59% | -59.36% | 37.94% | 267.49% |
Free Cash Flow Margin | 14.26% | 7.99% | 4.26% | 9.81% | 7.69% |
Free Cash Flow Per Share | 0.70 | 0.42 | 0.24 | 0.62 | 0.44 |
Cash Income Tax Paid | 401.58 | 491.62 | 535.67 | 418.09 | 414.3 |
Levered Free Cash Flow | -1,091 | -225.43 | 1,661 | 1,193 | 1,324 |
Unlevered Free Cash Flow | -1,091 | -185.1 | 1,709 | 1,251 | 1,399 |
Change in Working Capital | 80.09 | -444.68 | -665.92 | 313.23 | -114.77 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.